- Corporate Officers - S
- Schimmel Paul
Insider Trading History of Schimmel Paul
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Schimmel Paul since 2006.
This trader's CIK number is 1236447.
At the time of last reporting, Schimmel Paul was the Officer of Atyr Pharma Inc. (stock ticker symbol ATYR).
Also see all insider trading activities at Atyr Pharma Inc.
Note that in the past
SCHIMMEL PAUL also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Alkermes Inc (ALKS) by Schimmel Paul
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2007 | ALKS | 0 | $0 | 0 | $0 | 5,000 | $39,700 |
| 2006 | ALKS | 0 | $0 | 5,000 | $130,000 | 5,000 | $25,000 |
Yearly summary of insider trading at Repligen Corp (RGEN) by Schimmel Paul
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2007 | RGEN | 0 | $0 | 0 | $0 | 5,000 | $5,000 |
| 2006 | RGEN | 0 | $0 | 0 | $0 | 10,000 | $8,800 |
Yearly summary of insider trading at Sirtris Pharmaceuticals, Inc. (SIRT) by Schimmel Paul
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2007 | SIRT | 0 | $0 | 11,503 | $195,608 | 26,785 | $11,249 |
Yearly summary of insider trading at Alnylam Pharmaceuticals, Inc. (ALNY) by Schimmel Paul
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | ALNY | 0 | $0 | 27,823 | $4,173,450 | 27,823 | $1,420,837 |
| 2015 | ALNY | 0 | $0 | 20,000 | $2,500,200 | 20,000 | $559,649 |
| 2014 | ALNY | 0 | $0 | 45,000 | $4,280,400 | 45,000 | $807,300 |
| 2013 | ALNY | 0 | $0 | 30,000 | $1,875,000 | 30,000 | $309,450 |
| 2012 | ALNY | 93,023 | $999,997 | 0 | $0 | 0 | $0 |
| 2009 | ALNY | 0 | $0 | 75,000 | $1,657,703 | 0 | $0 |
| 2007 | ALNY | 0 | $0 | 56,000 | $1,852,613 | 20,000 | $218,200 |
| 2006 | ALNY | 100,000 | $1,300,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Forte Biosciences, Inc. (TOCA) by Schimmel Paul
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | TOCA | 10,000 | $100,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Atyr Pharma Inc (ATYR) by Schimmel Paul
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | ATYR | 100,000 | $184,627 | 0 | $0 | 0 | $0 |
| 2023 | ATYR | 200,000 | $450,000 | 0 | $0 | 6,000 | $0 |
| 2021 | ATYR | 300,000 | $2,199,000 | 0 | $0 | 0 | $0 |
| 2020 | ATYR | 254,000 | $1,079,500 | 8,447 | $30,738 | 0 | $0 |
| 2018 | ATYR | 504,385 | $382,241 | 0 | $0 | 0 | $0 |
| 2017 | ATYR | 94,336 | $249,990 | 0 | $0 | 0 | $0 |
| 2016 | ATYR | 367,840 | $1,213,916 | 0 | $0 | 0 | $0 |
Insider trading activities at 6 companies by Schimmel Paul:
1. Alkermes Inc (ALKS)
2. Repligen Corp (RGEN)
3. Sirtris Pharmaceuticals, Inc. (SIRT)
4. Alnylam Pharmaceuticals, Inc. (ALNY)
5. Forte Biosciences, Inc. (TOCA)
6. Atyr Pharma Inc (ATYR)
Table 1. Insider trading of Alkermes Inc (ALKS) by Schimmel Paul
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2007-06-15 | ALKS | Option Ex | 5,000 | 7.94 | 39,700 |
| 2006-03-02 | ALKS | Option Ex | 5,000 | 5.00 | 25,000 |
| 2006-03-02 | ALKS | Sale | 5,000 | 26.00 | 130,000 |
Table 2. Insider trading of Repligen Corp (RGEN) by Schimmel Paul
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2007-06-14 | RGEN | Option Ex | 5,000 | 1.00 | 5,000 |
| 2006-08-11 | RGEN | Option Ex | 5,000 | .88 | 4,400 |
| 2006-08-11 | RGEN | Option Ex | 5,000 | .88 | 4,400 |
Table 3. Insider trading of Sirtris Pharmaceuticals, Inc. (SIRT) by Schimmel Paul
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2007-11-30 | SIRT | Sale | 11,503 | 17.00 | 195,608 |
| 2007-11-30 | SIRT | Option Ex | 26,785 | .42 | 11,249 |
Table 4. Insider trading of Alnylam Pharmaceuticals, Inc. (ALNY) by Schimmel Paul
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-03-13 | ALNY | Sale | 27,823 | 150.00 | 4,173,450 |
| 2018-03-13 | ALNY | Option Ex | 27,823 | 51.07 | 1,420,837 |
| 2015-04-21 | ALNY | Sale | 10,000 | 130.02 | 1,300,200 |
| 2015-04-21 | ALNY | Option Ex | 10,000 | 28.68 | 286,850 |
| 2015-03-17 | ALNY | Option Ex | 947 | 27.28 | 25,834 |
| 2015-03-17 | ALNY | Sale | 947 | 120.00 | 113,640 |
| 2015-03-19 | ALNY | Option Ex | 9,053 | 27.28 | 246,965 |
| 2015-03-19 | ALNY | Sale | 9,053 | 120.00 | 1,086,360 |
| 2014-12-08 | ALNY | Option Ex | 15,000 | 22.09 | 331,350 |
| 2014-12-08 | ALNY | Sale | 15,000 | 105.00 | 1,575,000 |
| 2014-10-28 | ALNY | Option Ex | 15,000 | 15.91 | 238,650 |
| 2014-10-28 | ALNY | Sale | 15,000 | 95.00 | 1,425,000 |
| 2014-01-13 | ALNY | Option Ex | 15,000 | 15.82 | 237,300 |
| 2014-01-13 | ALNY | Sale | 15,000 | 85.36 | 1,280,400 |
| 2013-12-20 | ALNY | Option Ex | 15,000 | 11.33 | 169,950 |
| 2013-12-20 | ALNY | Sale | 15,000 | 65.00 | 975,000 |
| 2013-10-22 | ALNY | Option Ex | 15,000 | 9.30 | 139,500 |
| 2013-10-22 | ALNY | Sale | 15,000 | 60.00 | 900,000 |
| 2012-02-21 | ALNY | Buy | 93,023 | 10.75 | 999,997 |
| 2009-09-09 | ALNY | Sale | 30,000 | 22.10 | 662,940 |
| 2009-09-10 | ALNY | Sale | 15,600 | 22.26 | 347,287 |
| 2009-09-04 | ALNY | Sale | 29,400 | 22.02 | 647,476 |
| 2007-12-04 | ALNY | Sale | 7,192 | 31.89 | 229,352 |
| 2007-11-30 | ALNY | Sale | 37,222 | 33.45 | 1,245,187 |
| 2007-11-30 | ALNY | Option Ex | 20,000 | 10.91 | 218,200 |
| 2007-12-03 | ALNY | Sale | 11,586 | 32.63 | 378,074 |
| 2006-01-31 | ALNY | Buy | 100,000 | 13.00 | 1,300,000 |
Table 5. Insider trading of Forte Biosciences, Inc. (TOCA) by Schimmel Paul
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-04-19 | TOCA | Buy | 10,000 | 10.00 | 100,000 |
Table 6. Insider trading of Atyr Pharma Inc (ATYR) by Schimmel Paul
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-07-22 | ATYR | Buy | 41,052 | 1.74 | 71,512 |
| 2024-07-23 | ATYR | Buy | 6,648 | 1.82 | 12,072 |
| 2024-07-24 | ATYR | Buy | 52,300 | 1.93 | 101,043 |
| 2023-05-10 | LIFE | Buy | 200,000 | 2.25 | 450,000 |
| 2023-04-26 | LIFE | Option Ex | 6,000 | .00 | 0 |
| 2021-09-20 | LIFE | Buy | 250,000 | 8.00 | 2,000,000 |
| 2021-05-18 | LIFE | Buy | 50,000 | 3.98 | 199,000 |
| 2020-05-20 | LIFE | Sale | 8,447 | 3.64 | 30,738 |
| 2020-02-10 | LIFE | Buy | 254,000 | 4.25 | 1,079,500 |
| 2018-11-26 | LIFE | Buy | 147,225 | .54 | 79,795 |
| 2018-08-31 | LIFE | Buy | 22,000 | .72 | 15,752 |
| 2018-09-04 | LIFE | Buy | 20,749 | .76 | 15,706 |
| 2018-08-29 | LIFE | Buy | 75,136 | .72 | 54,097 |
| 2018-08-30 | LIFE | Buy | 89,275 | .76 | 67,491 |
| 2018-05-18 | LIFE | Buy | 150,000 | 1.00 | 149,400 |
| 2017-08-31 | LIFE | Buy | 94,336 | 2.65 | 249,990 |
| 2016-12-20 | LIFE | Buy | 15,000 | 2.27 | 34,110 |
| 2016-12-21 | LIFE | Buy | 10,000 | 2.28 | 22,820 |
| 2016-12-15 | LIFE | Buy | 40,000 | 2.50 | 99,920 |
| 2016-12-16 | LIFE | Buy | 10,000 | 2.40 | 23,969 |
| 2016-04-14 | LIFE | Buy | 66,219 | 4.18 | 276,927 |
| 2016-04-13 | LIFE | Buy | 9,835 | 3.85 | 37,864 |
| 2016-04-12 | LIFE | Buy | 9,127 | 3.73 | 34,007 |
| 2016-04-11 | LIFE | Buy | 32,659 | 3.52 | 114,959 |
| 2016-04-08 | LIFE | Buy | 85,000 | 3.22 | 273,615 |
| 2016-04-07 | LIFE | Buy | 40,000 | 3.19 | 127,600 |
| 2016-04-06 | LIFE | Buy | 25,000 | 3.20 | 80,000 |
| 2016-04-05 | LIFE | Buy | 25,000 | 3.52 | 88,125 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Schimmel Paul
(Officer of Atyr Pharma Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.